By Megan Redshaw | The Defender | March 14, 2022 Pfizer CEO Albert Bourla on Sunday told CBS “Face the Nation” a fourth dose of its COVID-19 vaccine will be necessary to maintain manageable levels of hospitalizations and mild infections. The company plans to submit data on a fourth dose to the U.S. Food and Drug Administration (FDA) and […]
Source